Jordan Raphel

Jordan Raphel is an accomplished professional in the fields of clinical and product development, with extensive experience in biopharmaceuticals, medical devices, and biotechnology. Currently serving as the Director of Clinical and Product Development at RedLeaf Biologics, Inc. since May 2022, Jordan has played a key role in developing natural phytochemical extracts for various markets. Prior to this, Jordan held leadership positions at Zetagen Therapeutics and Hyalex Orthopaedics, contributing to innovative treatments for bone cancer and advancements in orthopaedic materials. Educational credentials include a PhD and Master's degree in Materials Science & Engineering from Stanford University, along with a Bachelor's degree from Cornell University. Jordan's professional path also includes significant roles in research, market development, and entrepreneurial innovation, showcasing a commitment to advancing healthcare technologies.